SEC Form 4 · accession 0001171000-15-000017
Nexvet Biopharma plc · NVET
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Geraldine T Farrell
Officer — VP Operations, General Counsel
Period of report
Jun 8, 2015
Accepted (ET)
Jun 10, 2015 · 8:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618561
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jun 8, 2015 | A | 4,300 | $0.125 | A | 4,300 | D | |
| Ordinary SharesF1 | holding | — | — | — | 7,891 | I | By Geraldine Therese Farrell & Andrew John Benston <Bulla Bulla Family A/C> | |
| Ordinary SharesF2 | holding | — | — | — | 132 | I | By Nexvet EBT Limited |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person and her spouse shared voting and dispositive power with respect to these reported securities.
- F2The reporting person has sole voting and dispositive power over the reported securities pursuant to that certain Nominee Deed dated as of 11/14/14 by and between Nexvet EBT Limited and the persons named in the schedule hereto. Such Nominee Deed was executed in connection with the Issuer's November 2014 four-for-five share consolidation.